Literature DB >> 14715538

Relationship of binding of immunoglobulin G to Plasmodium falciparum-infected erythrocytes with parasite endemicity and antibody responses to conserved antigen in immune individuals.

Antoine-Marie Diatta1, Laurence Marrama, Adama Tall, Jean-François Trape, Alioune Dieye, Olivier Garraud, Odile Mercereau-Puijalon, Ronald Perraut.   

Abstract

To investigate the potential for use of a well-established strain of Plasmodium falciparum as a reference strain for infected red blood cell (IRBC) surface reactivity, we monitored the binding of specific immunoglobulin G (IgG) from immune individuals to the reference Knob-positive FCR3 strain by flow cytometry. To permit interassay comparison for 162 plasma samples drawn after the rainy season, a labeling index (LI) was defined as the percentage of labeled parasites multiplied by the mean peak intensity. An LI ratio (LIR) was then calculated as the LI of the sample divided by the LI of the control. LIRs were calculated for individuals living in Dielmo and Ndiop, two Senegalese villages where P. falciparum is transmitted holoendemically and mesoendemically, respectively. The incidence (persons with an LIR of >3) observed in Dielmo was lower than that observed in Ndiop. Significantly higher LIRs were observed (i) for samples from Ndiop than for samples from Dielmo (P < 0.01) and (ii) in Ndiop, in subjects with hemoglobin AS (HbAS) than in those with hemoglobin AA (P = 0.03). No correlation with the cumulative age-associated immune status of the villagers was evidenced, contrary to antibody (Ab) responses against conserved IRBC-associated antigen (Ag) measured by enzyme-linked immunosorbent assay. These results are consistent with the notions that protection in HbAS individuals may relate to an increased IgG response to IRBC membrane Ags and that cell surface reactivity parallels IgG responses even though it is in itself a distinct indicator of the anti-P. falciparum Ab response. Measures of IgG binding to live IRBC are thus relevant for the functional screening of conserved IRBC-associated Ags that contribute to parasite destruction in vivo, as these Ags might be included in a multitarget vaccine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715538      PMCID: PMC321335          DOI: 10.1128/cdli.11.1.6-11.2004

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  31 in total

1.  Protective effects of the sickle cell gene against malaria morbidity and mortality.

Authors:  Michael Aidoo; Dianne J Terlouw; Margarette S Kolczak; Peter D McElroy; Feiko O ter Kuile; Simon Kariuki; Bernard L Nahlen; Altaf A Lal; Venkatachalam Udhayakumar
Journal:  Lancet       Date:  2002-04-13       Impact factor: 79.321

2.  Plasmodium falciparum: analysis of the antibody specificity to the surface of the trophozoite-infected erythrocyte.

Authors:  K P Piper; D J Roberts; K P Day
Journal:  Exp Parasitol       Date:  1999-02       Impact factor: 2.011

3.  Novel target antigens of the variant-specific immune response to Plasmodium falciparum identified by differential screening of an expression library.

Authors:  C Le Scanf; T Fandeur; S Bonnefoy; M Guillotte; O Mercereau-Puijalon
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  Antibody reactivity to conserved linear epitopes of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1).

Authors:  T Staalsø; E A Khalil; I M Elhassan; E E Zijlstra; A M Elhassan; H A Giha; T G Theander; P H Jakobsen
Journal:  Immunol Lett       Date:  1998-02       Impact factor: 3.685

5.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

6.  Evaluation of immunogenicity and protective efficacy of carrier-free Plasmodium falciparum R23 antigen in pre-exposed saimiri sciureus monkeys.

Authors:  R Perraut; S Morales-Betoulle; C Le Scanf; E Bourreau; M Guillotte; S Bonnefoy; J Michel; O Mercereau-Puijalon
Journal:  Vaccine       Date:  2000-08-15       Impact factor: 3.641

7.  Malaria-induced acquisition of antibodies to Plasmodium falciparum variant surface antigens.

Authors:  Michael F Ofori; Daniel Dodoo; Trine Staalsoe; Jørgen A L Kurtzhals; Kwadwo Koram; Thor G Theander; Bartholomew D Akanmori; Lars Hviid
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

8.  The Pf332 gene of Plasmodium falciparum codes for a giant protein that is translocated from the parasite to the membrane of infected erythrocytes.

Authors:  D Mattei; A Scherf
Journal:  Gene       Date:  1992-01-02       Impact factor: 3.688

9.  The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal.

Authors:  J F Trape; C Rogier; L Konate; N Diagne; H Bouganali; B Canque; F Legros; A Badji; G Ndiaye; P Ndiaye
Journal:  Am J Trop Med Hyg       Date:  1994-08       Impact factor: 2.345

10.  Flow cytometry detection of surface antigens on fresh, unfixed red blood cells infected by Plasmodium falciparum.

Authors:  H Jouin; Y O Goguet de la Salmonière; C Behr; M Huyin Qan Dat; J C Michel; J L Sarthou; L Pereira da Silva; P Dubois
Journal:  J Immunol Methods       Date:  1995-02-13       Impact factor: 2.303

View more
  7 in total

1.  Hemoglobin variants shape the distribution of malaria parasites in human populations and their transmission potential.

Authors:  Bronner P Gonçalves; Issaka Sagara; Mamadou Coulibaly; Yimin Wu; Mahamadoun H Assadou; Agnes Guindo; Ruth D Ellis; Mahamadou Diakite; Erin Gabriel; D Rebecca Prevots; Ogobara K Doumbo; Patrick E Duffy
Journal:  Sci Rep       Date:  2017-10-27       Impact factor: 4.379

Review 2.  Biochemical and immunological mechanisms by which sickle cell trait protects against malaria.

Authors:  Lauren Gong; Sunil Parikh; Philip J Rosenthal; Bryan Greenhouse
Journal:  Malar J       Date:  2013-09-11       Impact factor: 2.979

3.  Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malaria.

Authors:  Hodan Ahmed Ismail; Muyideen K Tijani; Christine Langer; Linda Reiling; Michael T White; James G Beeson; Mats Wahlgren; Roseangela Nwuba; Kristina E M Persson
Journal:  Malar J       Date:  2014-11-05       Impact factor: 2.979

4.  Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity.

Authors:  Tatiana M Lopera-Mesa; Saibou Doumbia; Serena Chiang; Amir E Zeituni; Drissa S Konate; Mory Doumbouya; Abdoul S Keita; Kasia Stepniewska; Karim Traore; Seidina A S Diakite; Daouda Ndiaye; Juliana M Sa; Jennifer M Anderson; Michael P Fay; Carole A Long; Mahamadou Diakite; Rick M Fairhurst
Journal:  J Infect Dis       Date:  2013-02-28       Impact factor: 5.226

5.  Relationship between malaria incidence and IgG levels to Plasmodium falciparum merozoite antigens in Malian children: impact of hemoglobins S and C.

Authors:  Kazutoyo Miura; Mahamadou Diakite; Ababacar Diouf; Saibou Doumbia; Drissa Konate; Abdoul S Keita; Samuel E Moretz; Gregory Tullo; Hong Zhou; Tatiana M Lopera-Mesa; Jennifer M Anderson; Rick M Fairhurst; Carole A Long
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

6.  A flow cytometry-based workflow for detection and quantification of anti-plasmodial antibodies in vaccinated and naturally exposed individuals.

Authors:  Anthony Ajua; Thomas Engleitner; Meral Esen; Michael Theisen; Saadou Issifou; Benjamin Mordmüller
Journal:  Malar J       Date:  2012-11-06       Impact factor: 2.979

7.  Relationship between Antibody Levels, IgG Binding to Plasmodium falciparum-Infected Erythrocytes, and Disease Outcome in Hospitalized Urban Malaria Patients from Dakar, Sénégal.

Authors:  Babacar Mbengue; Mouhamadou Mansour Fall; Maguette Sylla Niang; Birahim Niang; Marie Louise Varela; Antoine Marie Diatta; Moustapha Mbow; Kantome Ndiaye; Rokhaya Ndiaye Diallo; Alioune Dieye; Ronald Perraut
Journal:  Biomed Res Int       Date:  2016-08-03       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.